Pricing Log in Create free account
Friday 6 November 2026 Export TVTX’s income statement to Excel — free account

Travere Therapeutics, Inc.

TVTX Healthcare Biotechnology

Travere Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $490.7 million, up 110.5% from fiscal 2024.

Revenue
+36.2%
EPS
−290.7%
Free cash flow
+6,379.8%
Total debt
+93.8%

Quarter to September 2026, against a year earlier

49.45 0.58 +1.19%
Market cap
$4.7B
P/E
0.0×
Fwd P/E
−145×
Dividend yield
—
F-score
6/9
Altman Z
1.78
Beneish M
−1.74
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Travere Therapeutics, Inc. (TVTX) Book value per share

Alert me on Book value per share

Travere Therapeutics, Inc.'s book value per share at the end of fiscal 2025 was 1.3×, up 71.9% from 0.7× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 0.2×. Over the past ten years it has ranged from 0.7× (fiscal 2022) to 8.9× (fiscal 2015); the current reading is higher than 27% of that period. Travere Therapeutics, Inc. ranks 445th of 611 Biotechnology companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 1.3× 71.87%
FY2024 0.7× (72.30%)
FY2023 2.7× 302.31%
FY2022 0.7× (86.69%)
FY2021 5.0× 13.65%
FY2020 4.4× (14.96%)
FY2019 5.2× (33.63%)
FY2018 7.9× 4.10%
FY2017 7.6× (9.11%)
FY2016 8.3× (6.93%)

Quarterly newest first

Period Book value per share Change
Sep 2026 0.2× (9.00%)
Jun 2026 0.3× (75.59%)
Mar 2026 1.1× (16.50%)
Dec 2025 1.3× 56.13%
43 more quarters

Against its own ten years

Low 0.7× High 8.9×
Ten-year median 5.0×
Current reading's percentile 27

Book value per share against peers

Company Book value per share
DNTH Dianthus Therapeutics, Inc. compare 21.6×
MANE Veradermics Incorporated compare 20.1×
CRSP CRISPR Therapeutics AG compare 17.0×
EWTX Edgewise Therapeutics, Inc. compare 15.0×
DFTX Definium Therapeutics, Inc. compare 8.3×
LEGN Legend Biotech Corporation Sponsored ADR compare 6.6×
COGT Cogent Biosciences, Inc. compare 3.1×
ERAS Erasca, Inc. compare 1.2×
TVTX Travere Therapeutics, Inc. 0.2×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on TVTX